Does digital IHC need digital tissue controls?
|
|
- Brent Thompson
- 6 years ago
- Views:
Transcription
1 VILNIUS UNIVERSITY Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system Arvydas Laurinavicius 12th European Congress on Digital Pathology Paris, France, June 2014
2 Does digital IHC need digital tissue controls? Conventional IHC staining quality is monitored by semiquantitative visual evaluation of tissue (multi)controls Image analysis may require more sensitive quality control Intra- and interlaboratory IHC staining variation may be a major obstacle for DIA adoption We have previously shown intra-laboratory HER2 IHC variation by digital analysis means
3 HER2 average membrane staining intensity variation Batch/Serial section # Laurinavicius, Besusparis, et al Diagnostic Pathology 2013.
4 Integrated IHC staining monitor by and for digital analysis Explore Ki67 IHC staining variation in our laboratory routine, set up LIS integration of the IHC tissue multi-controls, monitored by image analysis, and supported by automated statistical analysis feedback
5 Consecutive sections (n=69) of one TMA block containing 10 cores of breast cancer tissue used as tissue controls in routine Ki67 IHC testing Ventana slide label BarcodeID was sent to the LIS to register the serial section sequence, then used for statistical analyses Slides stained and scanned (Aperio ScanScope XT), IA performed by the Aperio/Leica Colocalization and Genie Classifier/Nuclear algorithms SQL-based SpectrumPlus/LIS integration ensured automated statistical analysis of the IA data by the SAS Enterprise Guide project Factor analysis and plot visualizations to explore slide-to-slide variation of the Ki67 IHC staining results in the control tissue
6 Workflow TMA block with 10 control tissue cores Serial sections stored at +4C Used on demand for routine Ki67 TMALAB design applied for the tissue controls Slides stained and scanned Ventana BarcodeID stored in LIS when slide label printed Colocalization Genie/Nuclear performed on the TMA and WSI SAS project rerun from the Spectrum/LIS SQL query Statistical feedback generated
7 Intraslide Intertissue Intraslide Intertissue
8 Variation of individual 10 spots
9 Slide-to-slide variation of the TMA multicontrols Total Nuclei Total Stained Area (mm2) Positive Nuclei Brown Intensity The sequence of Ventana slide Barcode on the x axis to represent consecutive serial sections of TMA blocks of the 10 multi-tissue control cores (labelled as SampleID),
10 Slide-to-slide variation of the TMA multicontrols Percent Positive Nuclei Blue Intensity Positive Density (Pos Nuclei/mm 2 ) Brown/Blue Intensity ratio The sequence of Ventana slide Barcode on the x axis to represent consecutive serial sections of TMA blocks of the 10 multi-tissue control cores (labelled as SampleID),
11 Factor pattern of Brown and Blue intensity indicators from Colocalization Analysis in 10 individual TMA cores Total Intensity Both Brown and Blue lighter Relatively deeper Blue Brown/Blue balance
12 e.g., Sum (Area) Sum (Total Nuclei) Median (Intensity) etc Variation of aggregated data from the 10 TMA spot images super-multi-tissue control
13 Factor pattern of Colocalization and Genie/Nuclear analysis outputs aggregated from 10 TMA cores IHC positivity High Ki67 LI, Dark Brown More tissue, Dark Blue Amount of Tissue Detected with Darker Blue
14 Relevant inverse covariation of selected image analysis variables Median Blue Intensity (Colocalization) Area of Analysis (Genie) Aggregated data from 10 TMA cores plotted against the sequence of Ventana Barcode on the x axis
15 The solution enabled continuous monitor of IHC multi-tissue controls by the means of IA, followed by automated statistical analysis, integrated into the laboratory workflow. Even in consecutive serial tissue sections, tissue-related factors affected the IHC IA results; meanwhile, less intense blue counterstain was associated with less amount of tissue, detected by the IA tools.
16 Remarks Scanning variation was not addressed in our experiment, same scanner used. The IA issues with hematoxylin counterstain in IHC, have been highlighted, alternative counterstaining and IA techniques have been proposed Brey at al J Histochem Cytochem 2003, Pham et al Diagn Pathol 2007, Stefanovic et albiotechnic & histochemistry 2013, Zehntner et al J Histochem Cytochem 2008, Bernardo et al Microsc Microanal 2009] Another approach - measuring signal-to-noise ratio of the images to evaluate quality before IA (Ali et al Br J Cancer 2013), however, adjustment of the images and/or analyses may require effort. Our data simulate reproducibility of the Ki67 index in the consecutive sections of one 1 mm diameter core: variation of Ki67% (the IA result) was satisfactory (standard deviation in all 10 cores ranged from 3 to 8, relative error within the range of 0.07 to 0.39) the variation of cell numbers detected (the process) was higher. Inter-laboratory IHC staining variation is likely to be more significant: international Ki67 reproducibility study (Polley et al J Natl Cancer Inst 2013) revealed unsatisfactory results of visual estimation which was even worse when the slides were stained locally. Further optimization and standardization of IHC procedures, especially, when applying IA tools with unknown sensitivity to the staining/scanning variation. Ideally, IA tools should be robust and resistant to the IHC staining and scanning variations.
17 Aida Laurinavičienė and Paulette Herlin Daiva Lesciute- Krilaviciene Yasir Iqbal Benoit Plancoulaine Darius Raudeliunas Raimundas Meškauskas Indra Baltrušaitytė, Justinas Besusparis A COMPREHENSIVE BIOMARKER INTRA- TUMOUR HETEROGENEITY EVALUATION BY DIGITAL IMMUNOHISTOCHEMISTRY IMAGE ANALYSIS This research is funded by European Social Fund under the Global Grant measure.
18
Education 2012 m. Vilnius University, National Cancer Institute, PhD studies 1995 m. Vilnius University, Faculty of Natural Sciences, Master s degree
CURRICULUM VITAE AIDA LAURINAVIČIENĖ 1968-05-05 PhD, Associate Professor Education 2012 m. Vilnius University, National Cancer Institute, PhD studies 1995 m. Vilnius University, Faculty of Natural Sciences,
More informationImage analysis in IHC overview, considerations and applications
Image analysis in IHC overview, considerations and applications Rasmus Røge, MD, Institute of Pathology, Aalborg University Hospital NordiQC workshop September 2016 Aalborg, Denmark Outline Theory Image
More informationAbstract. Background. Objective
Molecular epidemiology of clinical tissues with multi-parameter IHC Poster 237 J Ruan 1, T Hope 1, J Rheinhardt 2, D Wang 2, R Levenson 1, T Nielsen 3, H Gardner 2, C Hoyt 1 1 CRi, Woburn, Massachusetts,
More informationNext generation image analysis for immunohistochemistry quantitation
Next generation image analysis for immunohistochemistry quantitation Ben Vainer Department of Pathology, Rigshospitalet University of Copenhagen Medical Center Men are only so good as their technical developments
More informationNext-Gen Analytics in Digital Pathology
Next-Gen Analytics in Digital Pathology Cliff Hoyt, CTO Cambridge Research & Instrumentation April 29, 2010 Seeing life in a new light 1 Digital Pathology Today Acquisition, storage, dissemination, remote
More informationLayered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue
Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to
More informationInterpreting Therapeutic Response on Immune Cell Number and Spatial Distribution within the Tumor Microenvironment. Lorcan Sherry, CSO OracleBio
Interpreting Therapeutic Response on Immune Cell Number and Spatial Distribution within the Tumor Microenvironment Lorcan Sherry, CSO OracleBio Company Overview OracleBio is a specialised CRO providing
More informationAutomatic analysis of virtual slides to help in the determination of well established prognostic parameters in breast carcinomas
Loews hotel Le Concorde, Quebec Canada August 3-5, 2011 H.I.Q Automatic analysis of virtual slides to help in the determination of well established prognostic parameters in breast carcinomas N Elie 1,
More informationCOMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME
COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME Maria Lunardi MD Anatomic Pathology Fracastoro Hospital San Bonifacio, Verona -Italy HER2-neu
More informationVisual interpretation in pathology
13 Visual interpretation in pathology Tissue architecture (alteration) evaluation e.g., for grading prostate cancer Immunohistochemistry (IHC) staining scoring e.g., HER2 in breast cancer (companion diagnostic
More informationVirtual Microscopy: Express Surgical Pathology Consultation. Mercè Jordà, University of Miami, Florida
Virtual Microscopy: Express Surgical Pathology Consultation Mercè Jordà, University of Miami, Florida Telepathology versus Virtual microscopy (Digital Pathology) Telepathology Use of telecommunications
More informationHER2 ISH (BRISH or FISH)
Assessment Run H14 2018 HER2 ISH (BRISH or FISH) Material Table 1. Content of the multi-block used for the NordiQC HER2 ISH assessment, run H14 HER2 IHC* IHC score Dual - SISH** FISH*** FISH*** HER2/chr17
More informationHow to Best Prepare for Digital Pathology: A Primer on Technologies, Applications, and Clinical Contributions. Disclosures
How to Best Prepare for Digital Pathology: A Primer on Technologies, Applications, and Clinical Contributions Keith J. Kaplan, MD Carolinas Pathology Group Charlotte, NC 1 Disclosures Clarient,, Inc. Consulting
More informationSupplementary Online Content
Supplementary Online Content Rimm DL, Han G, Taube JM, et al. A prospective, multi-institutional, pathologistbased assessment of 4 immunohistochemistry assays for PD-L1 expression in non small cell lung
More informationCentral Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham
Central Pathology Review and Tissue MicroArrays Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham What is a tissue microarray? Tissue microarrays (TMAs) consist of paraffin blocks in which
More informationLOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN Mirette Hanna MD Clinical pathology PhD (candidate) Experimental medicine MSc Clinical and chemical
More informationDigital Pathology and CAP Guidelines
Digital Pathology and CAP Guidelines Frequently asked questions The VENTANA family of digital pathology products empowers you with the convenience of a comprehensive image and workflow solution. When used
More informationImmune Cell Phenotyping in Solid Tumors using Quantitative Pathology
Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology James R. Mansfield Director of Quantitative Pathology Applications 2009 PerkinElmer What is Quantitative Pathology? Quantitative Pathology
More informationThe following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details.
Disclaimer: The following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details. These slides are proprietary and should not
More informationDeveloping quantitative slide-based assays to assess target inhibition in oncology drug discovery and development
Developing quantitative slide-based assays to assess target inhibition in oncology drug discovery and development TIGA Workshop June 25-26, 2010 Doug Bowman Millennium Pharmaceuticals 2010 Millennium Pharmaceuticals
More informationQuality assurance and quality control in pathology in breast disease centers
Quality assurance and quality control in pathology in breast disease centers Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 1 st IBDC, 28 th January, 2011
More informationDeciphering the biology that drives response to immunotherapy
Deciphering the biology that drives response to immunotherapy Phenoptics TM Quantitative Pathology Platform Trent Norris, Field Application Scientist September 15, 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationDiagnostics Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Care Excellence
Diagnostics Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Care Excellence A rapid evidence review of the analytical validity of IHC4: ADDENDUM
More informationNordiQC External Quality Assurance in Immunohistochemistry
NordiQC External Quality Assurance in Immunohistochemistry Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark AALBORG (~ 200.000 inhabitants)
More informationIncorporating pharmacodynamic, response and patient selection biomarkers. Paul Elvin PhD Chief Translational Science Officer Aptus Clinical
Incorporating pharmacodynamic, response and patient selection biomarkers Paul Elvin PhD Chief Translational Science Officer Aptus Clinical 22 Oncology drug development Biomarkers key for: Strong hypothesis
More informationNext-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry
Nat Met, April 2014 Nat Med, April 2014 Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry Journal Club Timo Böge Overview Introduction Conventional Immunohistochemistry
More informationGaining New Insights Through IF Multiplexed Staining and Analysis. Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory October 5, 2017
Gaining New Insights Through IF Multiplexed Staining and Analysis Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory Assessing more from Tissue Sections Gaps with More Common Methods Most common
More informationStatistical Analysis of Biomarker Data
Statistical Analysis of Biomarker Data Gary M. Clark, Ph.D. Vice President Biostatistics & Data Management Array BioPharma Inc. Boulder, CO NCIC Clinical Trials Group New Investigator Clinical Trials Course
More informationLN04 - Lymphoma Tissue Microarray
Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA LN04 - Lymphoma Tissue Microarray
More informationAssessment Run B HER2 IHC
Assessment Run B26 208 HER2 IHC Material The slide to be stained for HER2 comprised the following 5 materials: IHC: HER2 Score* (0, +, 2+, 3+) FISH: HER2 gene/chr 7 ratio**. Breast carcinoma, no. 2+..3
More informationLessons learned in the use of digital imaging at Memorial Sloan Kettering Cancer Center
Lessons learned in the use of digital imaging at Memorial Sloan Kettering Cancer Center Executive War College May 3, 2018 Victor E. Reuter, M.D. Vice-Chair, Department of Pathology Medical Director, Warren
More informationUnderstanding your biomarker: what this marker can do for you
Understanding your biomarker: what this marker can do for you Dr. John Bartlett/Dr. Harriet Feilotter As is your Pathology, so is your Medicine. Sir William Osler. 1849-1919. Disclosure statement John
More informationAutomated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis
PROCEEDINGS Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis Open Access Marcial García-Rojo 1*, Joaquín Rodríguez Sánchez 2, Eva de la Santa 2, Elena Durán
More informationSupplementary Online Content
Supplementary Online Content Bell EH, Pugh SL, McElroy JP, et al. Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG Oncology
More informationData Mining for Research and Diagnostics
UCL DEPARTMENT OF GEOGRAPHY UCL INSTITUTE OF NEUROLOGY Data Mining for Research and Diagnostics Sebastian Brandner, UCL Institute of Neurology, London Data mining for Research and Diagnostics Our setup
More informationDigital Pathology - moving on after implementation. Catarina Eloy, MD, PhD
Digital Pathology - moving on after implementation Catarina Eloy, MD, PhD Catarina Eloy, MD, PhD No conflict of interests to declare Pathology challenges today Maintaining high quality students interested
More informationAssessment Run B HER2 IHC
Assessment Run B24 2017 HER2 IHC Material The slide to be stained for HER2 comprised the following 5 materials: IHC: HER2 Score* (0, 1+, 2+, 3+) FISH: HER2 gene/chr 17 ratio** 1. Breast carcinoma, no.
More informationProduct Introduction
Product Introduction Product Codes: HCL026, HCL027 and HCL028 Contents Introduction to HER2 2 HER2 immunohistochemistry 3 Cell lines as controls 5 HER2 Analyte Control DR IHC 7 HER2 Analyte Control DR
More informationCC01 - Colon Cancer Tissue Microarray
Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA CC01 - Colon Cancer Tissue Microarray
More informationAssessment Run GATA3
Assessment Run 44 2015 GATA3 Material The slide to be stained for GATA3 comprised: 1. Tonsil 2. Kidney, 3. Urothelial carcinoma, 4. Breast ductal carcinoma, 5. Colon adenocarcinoma All tissues were fixed
More informationDigital Pathology Diagnosis Assistance System
August 3, 2011 Digital Pathology Diagnosis Assistance System Computer s s eye and Pathologist s s eye Ogura M, Saito A, Graf HP, Marugame A, Kiyuna T, Yamashita Y, Cosatto E, Malon C & Fukumoto M. Innovative
More informationmanifestations of disease (mostly clinical medicine)
Histopathology : microscopic examination of tissue in order to study the manifestations of disease (mostly clinical medicine) https://medium.com/the-physics-arxiv-blog/ghost-imaging-reassembles-images-scattered-by-breast-tissue
More informationInterobserver Variability of Ki-67 Measurement in Breast Cancer
Journal of Pathology and Translational Medicine 2016; 50: 129-137 ORIGINAL ARTICLE Interobserver Variability of Ki-67 Measurement in Breast Cancer Yul Ri Chung 1 Min Hye Jang 2 So Yeon Park 1,2 Gyungyub
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY Methodology The test is based on the reported 50-gene classifier algorithm originally named PAM50 and is performed on the ncounter Dx Analysis System
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY GENE EXPRESSION PROFILING WITH PROSIGNA What is Prosigna? Prosigna Breast Cancer Prognostic Gene Signature Assay is an FDA-approved assay which provides
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-16-1-0737 TITLE: Developing a PTEN-ERG Signature to Improve Molecular Risk Stratification in Prostate Cancer PRINCIPAL INVESTIGATOR: Tamara Lotan CONTRACTING ORGANIZATION: Johns Hopkins
More informationUse of tissue micro array (TMA) in routine clinical analysis
2nd European Workshop on Tissue Imaging and Analysis June 25-26, 2010 Use of tissue micro array (TMA) in routine clinical analysis Tim Svenstrup Poulsen Molecular unit Dept. pathology Herlev Hospital Denmark
More informationTissue microarray TMA
Tissue microarray TMA Tibor Krenacs 1st Department of Pathology & Experimental Cancer Research Semmelweis University Budapest Austro-Hungarian Pathology Congress October 1-3rd 2009 TMA - tissue microarray
More informationFAQs for UK Pathology Departments
FAQs for UK Pathology Departments This is an educational piece written for Healthcare Professionals FAQs for UK Pathology Departments If you would like to discuss any of the listed FAQs further, or have
More informationARTIFICIAL INTELLIGENCE FOR DIGITAL PATHOLOGY. Kyunghyun Paeng, Co-founder and Research Scientist, Lunit Inc.
ARTIFICIAL INTELLIGENCE FOR DIGITAL PATHOLOGY Kyunghyun Paeng, Co-founder and Research Scientist, Lunit Inc. 1. BACKGROUND: DIGITAL PATHOLOGY 2. APPLICATIONS AGENDA BREAST CANCER PROSTATE CANCER 3. DEMONSTRATIONS
More informationAssessment Run B HER-2 IHC. HER-2/chr17 ratio**
Assessment Run B2 20 HER-2 IHC Material The slide to be stained for HER-2 comprised the following 5 tissues: IHC HER-2 Score* (0, +, 2+,3+) FISH HER-2/chr7 ratio**. Breast ductal carcinoma 0..3 2. Breast
More informationSpatially resolved multiparametric single cell analysis. Technical Journal Club 19th September 2017 Christina Müller (Group Speck)
Spatially resolved multiparametric single cell analysis Technical Journal Club 19th September 2017 Christina Müller (Group Speck) Why spatially resolved multiparametric single cell analysis? Multiparametric
More informationInterpretation guide. Abnormal cytology can t hide anymore
Interpretation guide Abnormal cytology can t hide anymore Unique dual-biomarker technology makes you certain about the presence of transforming HPV infection. The science that creates certainty. Table
More information# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer
#1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationMolecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.
Innovation for your breast cancer diagnostics Now valid ated on: -Roche cob as z 480 A nalyzer -Roche L ightcycle r 480 II - ABI 750 0 Fast -Versant kpcr Cyc ler PGR ESR1 MKI67 Molecular in vitro diagnostic
More informationOptimal algorithm for HER2 testing
Optimal algorithm for HER2 testing The revised definition of IHC 2+ (equivocal) is invasive breast cancer with Weak to moderate complete membrane staining observed in >10% of tumor cells. (see Figure 1
More informationBreast cancer: Antibody selection, protocol optimzation controls and EQA
Breast cancer: Antibody selection, protocol optimzation controls and EQA Workshop in Diagnostic Immunohistochemistry Oud St. Jan/ Old St. John Brugge (Bruges), Belgium June 13th 15nd 2018 Rasmus Røge,
More informationDefiniens. Tissue Studio 4.2. Tutorial 8: Cell Simulation and Classification
Definiens Tissue Studio 4.2 Tutorial 8: Cell Simulation and Classification Tutorial 8: Cell Simulation and Classification Imprint and Version Copyright 2015 Definiens AG. All rights reserved. This document
More informationMultiplex immunofluorescence for investigating the prognostic value of immune cells Chidozie Anyaegbu, PhD
Multiplex immunofluorescence for investigating the prognostic value of immune cells Chidozie Anyaegbu, PhD Catholic Health Australia Symposium Mater Hospital, Brisbane 1 st June 2018 Why colorectal cancer?
More informationIs digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK
Is digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK Pathologists and microscopes. 1850 Rudolph Virchow (1821-1902),
More informationTumor Growth Rate (TGR) A New Indicator of Antitumor Activity in NETS? IPSEN NET Masterclass Athens, 12 th November 2016
1 Tumor Growth Rate (TGR) A New Indicator of Antitumor Activity in NETS? IPSEN NET Masterclass Athens, 12 th November 2016 Philippe RUSZNIEWSKI ENETS Centre of Excellence, Beaujon Hospital, Clichy, France
More informationCINtec PLUS Cytology. Interpretation training
CINtec PLUS Cytology Interpretation training Objectives After reviewing this learning module, you will have a basic understanding of how to interpret CINtec PLUS Cytology, including: The mechanism of action
More informationCHEK Proficiency study 672. Phthalates in nail polish. Date 5 December 2017 Version 1. Report number CHEK
CHEK Proficiency study 672 Phthalates in nail polish Date 5 December 2017 Version 1 Status Final Report number CHEK-17-672 page 0 Colophon Number 672 Name Phthalates in nail polish Contact Author Authorization
More informationPositive Results on Fecal Blood Tests
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Results of a systematic review and Kaiser experience Kevin Selby, M.D. kevin.j.selby@kp.org National Colorectal Cancer Roundtable
More informationCENTRAL LABORATORY SERVICES
CENTRAL LABORATORY SERVICES Bridging the Gaps in Biomarker Development and Testing for Global Clinical Trials Biomarkers, Digital Pathology & the Central Lab Presentation Title Presenter Name July 16,
More informationMolecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.
Innovation for your breast cancer diagnostics PGR G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C ERBB2
More informationProduct Introduction. Product Codes: HCL029, HCL030 and HCL031. Issue
Product Introduction Product Codes: HCL029, HCL030 and HCL031 Issue 1. 180510 Contents Introduction to Estrogen Receptor 2 ER immunohistochemistry 3 Quality control 5 Cell lines as controls 6 Estrogen
More informationQuality Assurance and Quality Control in the Pathology Dept.
Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as
More informationApplying Tissue Phenomics to Colorectal Clinical Questions
Applying Tissue Phenomics to Colorectal Clinical Questions International Symposium for Tissue Phenomics San Francisco October 2014 Peter Caie Senior Research Fellow University of St Andrews Systems Pathology
More informationBackground Information
Background Information Erlangen, November 26, 2017 RSNA 2017 in Chicago: South Building, Hall A, Booth 1937 Artificial intelligence: Transforming data into knowledge for better care Inspired by neural
More informationResults you can trust
PRODUCT I NF OR MAT ION pharmdx Results you can trust The first and only FDA-approved PD-L1 test to assess the magnitude of treatment effect on progression-free survival in melanoma patients from OPDIVO
More informationAnalysis of Immunohistochemical Stain Usage in Different Pathology Practice Settings
Anatomic Pathology / Immunohistochemistry Use by Practice Type Analysis of Immunohistochemical Stain Usage in Different Pathology Practice Settings Akeesha A. Shah, MD, Henry F. Frierson, Jr, MD, and Helen
More informationApplication of tissue microarrays for receptor immunohistochemistry in breast carcinoma
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA Vol. 51, No. 4, 2013 pp. 326 332 ORIGINAL STUDY Application of tissue microarrays for receptor immunohistochemistry in breast carcinoma Anna Glajcar, Karolina Kaczmarczyk,
More informationWelcome! HER2 TESTING DIAGNOSTIC ACCURACY 4/11/2016
HER2 TESTING DIAGNOSTIC ACCURACY Can t We Finally Get It Right? Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Seattle, Washington Clinical Professor of Pathology University
More informationPROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT
PROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT Author: Dr Sally Ann Hales On behalf of the Breast and pathology CNGs Written: March 2005 Reviewed by CNG: June 2009 &
More informationComparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings
Experimental and Therapeutic Medicine 1: 927-932, 2010 Comparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings Koji Arihiro,
More informationIHC Stainer platforms. Overview, pros and cons
IHC Stainer platforms Overview, pros and cons Bart De Wiest Quality manager IHC OLV Hospital, Aalst, Belgium Donald Van Hecke Lab & Quality manager AZ St-Lucas, Brugge, Belgium Goal of this lecture: to
More informationP16 et Ki67 Biomarkers: new tool for risk management and low grade intraepithelial lesions (LGSIL): be ready for the future.
P16 et Ki67 Biomarkers: new tool for risk management and low grade intraepithelial lesions (LGSIL): be ready for the future. Mark H Stoler, MD University of Virginia Health System, Charlottesville, VA,
More informationVernieuwing en diagnostiek bij NSCLC: Immunotherapy: PD-L1 analyse: waar staan we
9e avondsymposium: "Nieuwe ontwikkelingen in de behandeling van NSCLC" 9 november 2016, UMCG Vernieuwing en diagnostiek bij NSCLC: Immunotherapy: PD-L1 analyse: waar staan we Wim Timens Professor and Chair
More informationComparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma
J Clin Pathol 1;54:951 955 951 Department of Pathology, University of Wales College of Medicine, Heath Park, CardiV, South Glamorgan, CF14 4XN, UK A G Douglas-Jones N Collett J M Morgan B Jasani Correspondence
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schuster SJ, Svoboda J, Chong EA, et al. Chimeric antigen receptor
More informationAida Laurinaviciene 1,2*, Darius Dasevicius 2,3, Valerijus Ostapenko 1, Sonata Jarmalaite 4, Juozas Lazutka 4 and Arvydas Laurinavicius 2,3.
METHODOLOGY Open Access Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm
More informationCME/SAM. Software-Automated Counting of Ki-67 Proliferation Index Correlates With Pathologic Grade and Disease Progression of Follicular Lymphomas
AJCP / Original Article Software-Automated Counting of Ki-67 Proliferation Index Correlates With Pathologic Grade and Disease Progression of Follicular Lymphomas Mark A. Samols, MD, PhD, 1 Nathan E. Smith,
More informationIDH1 R132H/ATRX Immunohistochemical validation
IDH1 R132H/ATRX Immunohistochemical validation CIQC/DSM 2016 12 June 2016 0835-0905 Stephen Yip, M.D., Ph.D., FRCPC University of British Columbia Disclosure Statement I have nothing to disclose I will
More informationInti Zlobec 1*, Viktor H Koelzer 1,2, Heather Dawson 1,2, Aurel Perren 1,2 and Alessandro Lugli 1,2
Zlobec et al. Journal of Translational Medicine 2013, 11:104 RESEARCH Open Access Next-generation tissue microarray (ngtma) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO
More informationExpanded View Figures
EMO Molecular Medicine Proteomic map of squamous cell carcinomas Hanibal ohnenberger et al Expanded View Figures Figure EV1. Technical reproducibility. Pearson s correlation analysis of normalised SILC
More informationDr. dr. Primariadewi R, SpPA(K)
Curriculum Vitae Dr. dr. Primariadewi R, SpPA(K) Education : Medical Doctor from UKRIDA Doctoral Degree from Faculty of Medicine University of Indonesia Pathologist Specialist and Consultant from Faculty
More informationDetection Of Red Lesion In Diabetic Retinopathy Using Adaptive Thresholding Method
Detection Of Red Lesion In Diabetic Retinopathy Using Adaptive Thresholding Method Deepashree Devaraj, Assistant Professor, Instrumentation Department RVCE Bangalore. Nagaveena M.Tech Student, BMSP&I,
More informationMeasuring cell density in prostate cancer imaging as an input for radiotherapy treatment planning
Measuring cell density in prostate cancer imaging as an input for radiotherapy treatment planning Poster No.: R-0262 Congress: 2014 CSM Type: Scientific Exhibit Authors: H. Reynolds, S. Williams, A. Zhang,
More informationUCL-Advanced Diagnostics. 2015/16 Service Update
UCL-Advanced Diagnostics 2015/16 Service Update About UCL-Advanced Diagnostics UCL Advanced Diagnostics (UCL-AD) is the immunohistochemistry, in situ and molecular diagnostics service arm of the UCL-Cancer
More informationPathfinder Holter Analyzer CARDIAC DIAGNOSTIC SOLUTIONS
Pathfinder Holter Analyzer CARDIAC DIAGNOSTIC SOLUTIONS Pathfinder Digital - An Evolution... Del Mar Reynolds rich history of innovation began nearly a half century ago with the development of Holter monitoring
More informationClassification of electrocardiographic ST-T segments human expert vs artificial neural network
European Heart Journal (1993) 14,464-468 Classification of electrocardiographic ST-T segments human expert vs artificial neural network L. EDENBRANDT, B. DEVINE AND P. W. MACFARLANE University Department
More informationUtilization of Virtual Microscopy in a Cooperative Group Setting
Utilization of Virtual Microscopy in a Cooperative Group Setting The Research Institute at Nationwide Children s Hospital Research Informatics Core Biopathology Center Tom Barr Bill Beyer Dave Billiter
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-11-1-0380 TITLE: Validation of Biomarkers for Prostate Cancer Prognosis PRINCIPAL INVESTIGATOR: James D Brooks CONTRACTING ORGANIZATION: Stanford University Stanford, CA, 94305.
More informationANALYTISCHE STRATEGIE Tissue Imaging. Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich
ANALYTISCHE STRATEGIE Tissue Imaging Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich Quantitative Breast single cancer cell analysis Switzerland Brain Breast Lung Colon-rectum
More informationImmunotherapy in NSCLC Pathologist role
Immunotherapy in NSCLC Pathologist role Pimpin Incharoen, M.D. Assistant Professor, Thoracic Pathology Department of Pathology, Ramathibodi Hospital Genetic alterations in NSCLC Khono et al, Trans Lung
More informationIdentification of Sickle Cells using Digital Image Processing. Academic Year Annexure I
Academic Year 2014-15 Annexure I 1. Project Title: Identification of Sickle Cells using Digital Image Processing TABLE OF CONTENTS 1.1 Abstract 1-1 1.2 Motivation 1-1 1.3 Objective 2-2 2.1 Block Diagram
More information